Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Tofacitinib might be used to treat hair loss.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The combination therapy was effective and well-tolerated, especially in young patients.

Switching to generic tacrolimus was safe, effective, and saved money.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib taken by mouth helps treat hair loss in children.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

HAC and BAC improve skin targeting and reduce diffusion without causing irritation.